http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107625764-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-16 |
| filingDate | 2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107625764-B |
| titleOfInvention | Application of euphorbia ebracteolata B in preparing medicine for preventing and treating diseases related to nerve cell injury |
| abstract | The invention discloses a new application of a medicine of euphorbia stellera chamaejasme L.B, in particular to an application of euphorbia stellera chamaejasme L.B in preparing medicines for preventing and treating related diseases of nerve cell injury such as cerebral ischemic diseases, cerebral ischemia reperfusion injury, oxidative stress brain injury, cerebral ischemia sequelae and the like. The Chinese stellera root extract B is obtained by separating ethanol extract from the root of Chinese stellera of Thymelaeaceae, and has a structure characterized in that two flavanones are connected with each other through a C-3 carbon-carbon single bond to form dihydroflavone. The inventor finds that the compound has a remarkable protective effect on ischemic brain injury in the evaluation of pharmaceutical activity, and can be used as a medicament for resisting diseases related to nerve cell injury such as cerebral ischemia and the like in clinic. |
| priorityDate | 2017-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 166.